Oncomine Comprehensive Panel, Oncomine Tumor Mutation Burden (TMB), MSI, PDL1
Introduction to the Oncomine Comprehensive Panel
The Oncomine Comprehensive Panel, Oncomine Tumor Mutation Burden (TMB), MSI, PDL1 is a revolutionary genetic test that plays a vital role in modern oncology. This panel is designed to analyze tumor tissue and peripheral blood to identify specific genetic mutations that can influence treatment decisions for cancer patients. Understanding these mutations is crucial for developing personalized treatment strategies, thereby improving patient outcomes.
What the Test Measures
This comprehensive test measures several key parameters, including:
- Oncomine Tumor Mutation Burden (TMB): Indicates the total number of mutations present in the tumor.
- Microsatellite Instability (MSI): Assesses the stability of the tumor’s DNA.
- PD-L1 Expression: Evaluates the presence of a protein that can inhibit immune response against tumors.
Who Should Consider This Test?
This test is particularly recommended for individuals who:
- Have a personal or family history of cancer.
- Exhibit symptoms associated with malignancies.
- Are considering immunotherapy or targeted therapies.
Benefits of Taking the Test
Taking the Oncomine Comprehensive Panel offers numerous benefits:
- Provides critical information for personalized cancer treatment.
- Helps oncologists make informed decisions regarding therapies.
- Can identify potential eligibility for clinical trials.
Understanding Your Results
Results from the Oncomine Comprehensive Panel can provide insights into the nature of the tumor and guide treatment options. It is essential to discuss the results with your healthcare provider, who can interpret the findings in the context of your overall health and treatment goals.
Test Pricing
| Price Type | Amount (KSh) |
|---|---|
| Discount Price | 240000 |
| Regular Price | 320000 |
Additional Information
Turnaround time for results is approximately 2-3 weeks. The test requires tumor tissue and peripheral blood samples, specifically paraffin embedded tissue blocks and an EDTA Vacutainer (3 ml).
Pre-test instructions indicate that the Oncomine Comprehensive Panel can be conducted with a Doctor’s prescription. However, this prescription is not applicable for individuals undergoing surgery, pregnant women, or those planning to travel abroad.
Book Your Test Today!
We have branches across Kenya, including major cities like Nairobi, Mombasa, and Kisumu. For convenience, we also offer home sample collection services. To book the Oncomine Comprehensive Panel, Oncomine Tumor Mutation Burden (TMB), MSI, PDL1 test, please call or WhatsApp us at +254711564616.
